Letter: comparative efficacy of biological therapy in patients with ulcerative colitis

被引：4
|
作者：
Singh, S. [1 ]
Garg, S. K. [2 ]
Wang, Z. [3 ]
Murad, M. H. [3 ]
Loftus, E. V., Jr. [1 ]
机构：
[1] Mayo Clin, Div Gastroenterol & Hepatol, Dept Internal Med, Rochester, MN 55905 USA
[2] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA
[3] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 12期
关键词：
NETWORK METAANALYSIS;
D O I：
10.1111/apt.12760
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1432 / 1433
页数：2
相关论文
共 50 条
  • [1] Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis
    Singh, S.
    Heien, H. C.
    Sangaralingham, L. R.
    Schilz, S. R.
    Kappelman, M. D.
    Shah, N. D.
    Loftus, E. V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (09) : 994 - 1003
  • [2] The safety of biological pharmacotherapy for the treatment of ulcerative colitis
    Fiorino, Gionata
    Bonovas, Stefanos
    Cicerone, Clelia
    Allocca, Mariangela
    Furfaro, Federica
    Correale, Carmen
    Danese, Silvio
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 437 - 443
  • [3] Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis
    Renna, S.
    Orlando, E.
    Macaluso, F. S.
    Maida, M.
    Affronti, M.
    Giunta, M.
    Sapienza, C.
    Rizzuto, G.
    Orlando, R.
    Dimarco, M.
    Cottone, M.
    Orlando, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (03) : 310 - 311
  • [4] Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy
    Mizoshita, Tsutomu
    Katano, Takahito
    Tanida, Satoshi
    Hirano, Atsuyuki
    Miyaki, Tomokatsu
    Ozeki, Keiji
    Suzuki, Yuka
    Sugimura, Naomi
    Kataoka, Hiromi
    Joh, Takashi
    MEDICINE, 2017, 96 (32)
  • [5] Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative Colitis
    Ananthakrishnan, Ashwin N.
    Cagan, Andrew
    Cai, Tianxi
    Gainer, Vivian S.
    Shaw, Stanley Y.
    Savova, Guergana
    Churchill, Susanne
    Karlson, Elizabeth W.
    Kohane, Isaac
    Liao, Katherine P.
    Murphy, Shawn N.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (04) : 880 - 885
  • [6] Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis
    Davis, Rebecca
    McParland, Paula
    Dodd, Susanna
    Storey, Daniel
    Probert, Chris
    Collins, Paul
    Skouras, Thomas
    Steel, Alan
    Derbyshire, Edmund
    Dibb, Martyn
    Subramanian, Sreedhar
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (06) : 661 - 667
  • [7] Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis
    Ananthakrishnan, Ashwin N.
    Murad, M. Hassan
    Scott, Frank I.
    Agrawal, Manasi
    Haydek, John P.
    Limketkai, Berkeley N.
    Loftus, Edward V., Jr.
    Singh, Siddharth
    GASTROENTEROLOGY, 2024, 167 (07) : 1460 - 1482
  • [8] Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
    Xinqiao Chu
    Yaning Biao
    Chengjiang Liu
    Yixin Zhang
    Chenxu Liu
    Ji-zheng Ma
    Yufeng Guo
    Yaru Gu
    BMC Gastroenterology, 23
  • [9] Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
    Chu, Xinqiao
    Biao, Yaning
    Liu, Chengjiang
    Zhang, Yixin
    Liu, Chenxu
    Ma, Ji-Zheng
    Guo, Yufeng
    Gu, Yaru
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [10] Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis
    Mao, E. J.
    Hazlewood, G. S.
    Kaplan, G. G.
    Peyrin-Biroulet, L.
    Ananthakrishnan, A. N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (01) : 3 - 13
12345